Key result
CIED presence shows no significant increase in recurrent tricuspid regurgitation after LuX-Valve replacement.
Why the study?
Does the presence of cardiac implantable electronic devices (CIEDs) affect recurrent tricuspid regurgitation in patients undergoing TTVR with the LuX-Valve?
Observational
Does the presence of cardiac implantable electronic devices (CIEDs) affect recurrent tricuspid regurgitation in patients undergoing TTVR with the LuX-Valve?
p-value: p=not statistically significant
The clinical implications of CIEDs on recurrent TR after LuX-Valve TTVR remain uncertain, highlighting a need for further investigation.
Transcatheter tricuspid valve replacement (TTVR) effectively reduces tricuspid regurgitation (TR) to ≤mild severity in most patients and improves functional status. Although the LuX-Valve (Jenscare) has demonstrated encouraging outcomes, recurrent TR has been reported to be numerically higher—though not statistically significant—among patients with cardiac implantable electronic devices (CIEDs), rendering its clinical implications uncertain.
No takes yet. Share an insight, caveat, or question.
Alnasser et al. (2026) conducted an observational in Tricuspid regurgitation post-transcatheter tricuspid valve replacement. Cardiac implantable electronic devices (CIEDs) vs. No CIEDs was evaluated on Recurrent tricuspid regurgitation (p=not statistically significant). Patients with cardiac implantable electronic devices had numerically, but not statistically significantly, higher rates of recurrent tricuspid regurgitation after LuX-Valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: